For: |
Kim KH, Choi JS, Kim IJ, Ku JL, Park JG. Promoter hypomethylation and reactivation of |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i35/5651.htm |
Number | Citing Articles |
1 |
Franco Andrés Pascucci, Micaela Carolina Escalada, Melisa Suberbordes, Candela Vidal, María Fátima Ladelfa, Martín Monte. MAGE-I proteins and cancer-pathways: A bidirectional relationship. Biochimie 2023; 208: 31 doi: 10.1016/j.biochi.2022.11.005
|
2 |
Chang-Ho Jeon, Han-IL Lee, Im-Hee Shin, Jong-Wook Park. Genetic alterations of APC, K-ras, p53, MSI, and MAGE in Korean colorectal cancer patients. International Journal of Colorectal Disease 2007; 23(1): 29 doi: 10.1007/s00384-007-0373-0
|
3 |
Fang Wu, Fang Liu, Lemei Dong, Han Yang, Xixi He, Lili Li, Lihao Zhao, Sisi Jin, Gang Li. miR-1273g silences MAGEA3/6 to inhibit human colorectal cancer cell growth via activation of AMPK signaling. Cancer Letters 2018; 435: 1 doi: 10.1016/j.canlet.2018.07.031
|
4 |
Yuquan Lin, Ti Wen, Xianyi Meng, Zhenzhou Wu, Liqing Zhao, Puyue Wang, Zhangyong Hong, Zhinan Yin. The mouse Mageb18 gene encodes a ubiquitously expressed type I MAGE protein and regulates cell proliferation and apoptosis in melanoma B16-F0 cells. Biochemical Journal 2012; 443(3): 779 doi: 10.1042/BJ20112054
|
5 |
Shao-shuai Wang, Fu-yuan Qiao, Ling Feng, Juan-juan Lv. Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome in China. Journal of Zhejiang University SCIENCE B 2008; 9(2): 93 doi: 10.1631/jzus.B0710599
|
6 |
Shuyun Hou, Meixiang Sang, Lianmei Zhao, Ran Hou, Baoen Shan. The expression of MAGE-C1 and MAGE-C2 in breast cancer and their clinical significance. The American Journal of Surgery 2016; 211(1): 142 doi: 10.1016/j.amjsurg.2015.05.028
|
7 |
Igor P. Pogribny, Frederick A. Beland. DNA hypomethylation in the origin and pathogenesis of human diseases. Cellular and Molecular Life Sciences 2009; 66(14): 2249 doi: 10.1007/s00018-009-0015-5
|
8 |
John P. Brabson, Tiffany Leesang, Sofia Mohammad, Luisa Cimmino. Epigenetic Regulation of Genomic Stability by Vitamin C. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.675780
|
9 |
Zdenko Herceg, Paolo Boffetta. Environmental Factors, Genes, and the Development of Human Cancers. 2010; : 153 doi: 10.1007/978-1-4419-6752-7_7
|
10 |
F. Javier Carmona, Manel Esteller. Metastasis of Colorectal Cancer. Cancer Metastasis - Biology and Treatment 2010; 14: 101 doi: 10.1007/978-90-481-8833-8_4
|
11 |
Hayden Pearce, Paul Hutton, Shalini Chaudhri, Emilio Porfiri, Prashant Patel, Richard Viney, Paul Moss. Spontaneous CD4+ and CD8+ T‐cell responses directed against cancer testis antigens are present in the peripheral blood of testicular cancer patients. European Journal of Immunology 2017; 47(7): 1232 doi: 10.1002/eji.201646898
|
12 |
Shenghui Liu, Yan Zhao, Yuru Xu, Meixiang Sang, Ruili Zhao, Lina Gu, Baoen Shan. The clinical significance of methylation of MAGE-A1 and-A3 promoters and expression of DNA methyltransferase in patients with laryngeal squamous cell carcinoma. American Journal of Otolaryngology 2020; 41(1): 102318 doi: 10.1016/j.amjoto.2019.102318
|
13 |
Mikhlid H. Almutairi, Mona M. Alotaibi, Rasha Alonaizan, Bader O. Almutairi, Hafiz Ishfaq Ahmad. Expression Profile of MAGE-B1 Gene and Its Hypomethylation Activation in Colon Cancer. BioMed Research International 2022; 2022: 1 doi: 10.1155/2022/6066567
|
14 |
Aixia Chen, Shengnan Zhao, Fei Zhou, Hongying Lv, Donghai Liang, Tao Jiang, Rui Liu, Lijin Zhu, Jingyu Cao, Shihai Liu, Hongsheng Yu. Identification of potential immune-related prognostic biomarkers of lung cancer using gene co-expression network analysis*. Oncology and Translational Medicine 2020; 6(6): 247 doi: 10.1007/s10330-020-0437-7
|
15 |
Richard Daifuku, Yu Zhang, Jingjing Wang, Qingyang Gu. iMN041 is an immunotherapeutic and an effective treatment in mouse xenograft models of pancreatic cancer, renal cancer and triple negative breast cancer. Translational Medicine Communications 2024; 9(1) doi: 10.1186/s41231-024-00161-3
|
16 |
Karolina Skowronki, Joseph Andrews, David I. Rodenhiser, Brenda L. Coomber, Hassan Brim. Genome-Wide Analysis in Human Colorectal Cancer Cells Reveals Ischemia-Mediated Expression of Motility Genes via DNA Hypomethylation. PLoS ONE 2014; 9(7): e103243 doi: 10.1371/journal.pone.0103243
|
17 |
Lorenz Kulzer, Yvonne Rubner, Lisa Deloch, Andrea Allgäuer, Benjamin Frey, Rainer Fietkau, Jan Dörrie, Niels Schaft, Udo S. Gaipl. Norm- and hypo-fractionated radiotherapy is capable of activating human dendritic cells. Journal of Immunotoxicology 2014; 11(4): 328 doi: 10.3109/1547691X.2014.880533
|
18 |
Xiang Li, Qian Mei, Jing Nie, Xiaobing Fu, Weidong Han. Decitabine: a promising epi-immunotherapeutic agent in solid tumors. Expert Review of Clinical Immunology 2015; 11(3): 363 doi: 10.1586/1744666X.2015.1002397
|
19 |
Mikhlid H. Almutairi, Mona M. Alotaibi, Rasha Alonaizan, Abdulwahed F. Alrefaei, Bader O. Almutairi. Identification of MAGE-A family genes in colon cancer patients and their expression mechanism. Journal of King Saud University - Science 2022; 34(7): 102251 doi: 10.1016/j.jksus.2022.102251
|
20 |
LI-PING XIA, MIN XU, YAN CHEN, WEI-WEI SHAO. Expression of MAGE-A11 in breast cancer tissues and its effects on the proliferation of breast cancer cells. Molecular Medicine Reports 2013; 7(1): 254 doi: 10.3892/mmr.2012.1126
|
21 |
Xiaotu Ma, Yi-Wei Wang, Michael Q Zhang, Adi F Gazdar. DNA Methylation Data Analysis and its Application to Cancer Research. Epigenomics 2013; 5(3): 301 doi: 10.2217/epi.13.26
|
22 |
M P Tan, A B Gerry, J E Brewer, L Melchiori, J S Bridgeman, A D Bennett, N J Pumphrey, B K Jakobsen, D A Price, K Ladell, A K Sewell. T cell receptor binding affinity governs the functional profile of cancer-specific CD8+ T cells. Clinical and Experimental Immunology 2015; 180(2): 255 doi: 10.1111/cei.12570
|
23 |
Yan He, Yue Hu, Yunsheng Cheng, Xutong Li, Chuanhong Chen, Shijie Zhang, Huihu He, Feng Cao. Multi-Omics Insights into Disulfidptosis-Related Genes Reveal RPN1 as a Therapeutic Target for Liver Cancer. Biomolecules 2024; 14(6): 677 doi: 10.3390/biom14060677
|
24 |
|
25 |
Zhixiong Zhang, Guan Wang, Yuyan Li, Dongsheng Lei, Jin Xiang, Liang Ouyang, Yanyan Wang, Jinliang Yang. Recent progress in DNA methyltransferase inhibitors as anticancer agents. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1072651
|
26 |
Marta Kulis, Manel Esteller. Epigenetics and Cancer, Part A. Advances in Genetics 2010; 70: 27 doi: 10.1016/B978-0-12-380866-0.60002-2
|
27 |
Hoi‐Hung Cheung, Tin‐Lap Lee, Owen M. Rennert, Wai‐Yee Chan. DNA methylation of cancer genome. Birth Defects Research Part C: Embryo Today: Reviews 2009; 87(4): 335 doi: 10.1002/bdrc.20163
|
28 |
Shu-yun Hou, Mei-xiang Sang, Cui-zhi Geng, Wei-hua Liu, Wei-hua Lü, Ying-ying Xu, Bao-en Shan. Expressions of MAGE-A9 and MAGE-A11 in Breast Cancer and their Expression Mechanism. Archives of Medical Research 2014; 45(1): 44 doi: 10.1016/j.arcmed.2013.10.005
|
29 |
Fangyan Yu, Farzana Ahmed, Stavroula Smilkou, Sayeda Yasmin-Karim, Farzaneh Darbeheshti, Athina Markou, Martyn Bullock, Ioannis Boukovinas, Viktor A Adalsteinsson, Evi Lianidou, G Mike Makrigiorgos. Pyrimidine-Dependent UV-Mediated Cross-Linking Magnifies Minor Genetic or Epigenetic Changes in Clinical Samples. Clinical Chemistry 2024; 70(9): 1151 doi: 10.1093/clinchem/hvae086
|
30 |
Ai-Niu Ma, Wei-Lin Huang, Zhong-Nan Wu, Ji-Fan Hu, Tao Li, Xiang-Jun Zhou, Yong-Xiang Wang. Induced epigenetic modifications of the promoter chromatin silence survivin and inhibit tumor growth. Biochemical and Biophysical Research Communications 2010; 393(4): 592 doi: 10.1016/j.bbrc.2010.02.020
|